The company has received final abbreviated new drug application (ANDA) approval from the US Food and Drug Administration (USFDA) for Irbesartan tablets, Unichem Laboratories said in a filing to the BSE.

The tablets are therapeutically equivalent to Sanofi- aventis's Avapro tablets, which are indicated for the treatment of hypertension. It is also used for the treatment of diabetic nephropathy.

Unichem stock was trading at Rs 283.70, up 2.94 percent,on BSE.

Latest News  from Business News Desk